Copyright Reports & Markets. All rights reserved.

Global Small Molecule Targted Drug Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Small Molecule Targted Drug Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 TKI
    • 1.2.3 Multitarget Inhibitor
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Small Molecule Targted Drug Market Share by Application: 2020 VS 2026
    • 1.3.2 Liver Cancer
    • 1.3.3 Colorectal Cancer
    • 1.3.4 Lung Cancer
    • 1.3.5 Gastric Cancer
    • 1.3.6 Breast Cancer
    • 1.3.7 Esophageal Cancer
    • 1.3.8 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Small Molecule Targted Drug Market Perspective (2015-2026)
  • 2.2 Global Small Molecule Targted Drug Growth Trends by Regions
    • 2.2.1 Small Molecule Targted Drug Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Small Molecule Targted Drug Historic Market Share by Regions (2015-2020)
    • 2.2.3 Small Molecule Targted Drug Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Small Molecule Targted Drug Players by Market Size
    • 3.1.1 Global Top Small Molecule Targted Drug Players by Revenue (2015-2020)
    • 3.1.2 Global Small Molecule Targted Drug Revenue Market Share by Players (2015-2020)
  • 3.2 Global Small Molecule Targted Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Small Molecule Targted Drug Revenue
  • 3.4 Global Small Molecule Targted Drug Market Concentration Ratio
    • 3.4.1 Global Small Molecule Targted Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targted Drug Revenue in 2019
  • 3.5 Key Players Small Molecule Targted Drug Area Served
  • 3.6 Key Players Small Molecule Targted Drug Product Solution and Service
  • 3.7 Date of Enter into Small Molecule Targted Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Small Molecule Targted Drug Breakdown Data by Type (2015-2026)

  • 4.1 Global Small Molecule Targted Drug Historic Market Size by Type (2015-2020)
  • 4.2 Global Small Molecule Targted Drug Forecasted Market Size by Type (2021-2026)

5 Small Molecule Targted Drug Breakdown Data by Application (2015-2026)

  • 5.1 Global Small Molecule Targted Drug Historic Market Size by Application (2015-2020)
  • 5.2 Global Small Molecule Targted Drug Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Small Molecule Targted Drug Market Size (2015-2026)
  • 6.2 North America Small Molecule Targted Drug Market Size by Type (2015-2020)
  • 6.3 North America Small Molecule Targted Drug Market Size by Application (2015-2020)
  • 6.4 North America Small Molecule Targted Drug Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Small Molecule Targted Drug Market Size (2015-2026)
  • 7.2 Europe Small Molecule Targted Drug Market Size by Type (2015-2020)
  • 7.3 Europe Small Molecule Targted Drug Market Size by Application (2015-2020)
  • 7.4 Europe Small Molecule Targted Drug Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Small Molecule Targted Drug Market Size (2015-2026)
  • 8.2 China Small Molecule Targted Drug Market Size by Type (2015-2020)
  • 8.3 China Small Molecule Targted Drug Market Size by Application (2015-2020)
  • 8.4 China Small Molecule Targted Drug Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Small Molecule Targted Drug Market Size (2015-2026)
  • 9.2 Japan Small Molecule Targted Drug Market Size by Type (2015-2020)
  • 9.3 Japan Small Molecule Targted Drug Market Size by Application (2015-2020)
  • 9.4 Japan Small Molecule Targted Drug Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Small Molecule Targted Drug Market Size (2015-2026)
  • 10.2 Southeast Asia Small Molecule Targted Drug Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Small Molecule Targted Drug Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Small Molecule Targted Drug Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Astrazeneca
    • 11.1.1 Astrazeneca Company Details
    • 11.1.2 Astrazeneca Business Overview
    • 11.1.3 Astrazeneca Small Molecule Targted Drug Introduction
    • 11.1.4 Astrazeneca Revenue in Small Molecule Targted Drug Business (2015-2020))
    • 11.1.5 Astrazeneca Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Small Molecule Targted Drug Introduction
    • 11.2.4 Novartis Revenue in Small Molecule Targted Drug Business (2015-2020)
    • 11.2.5 Novartis Recent Development
  • 11.3 Millennium Pharmaceuticals
    • 11.3.1 Millennium Pharmaceuticals Company Details
    • 11.3.2 Millennium Pharmaceuticals Business Overview
    • 11.3.3 Millennium Pharmaceuticals Small Molecule Targted Drug Introduction
    • 11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Targted Drug Business (2015-2020)
    • 11.3.5 Millennium Pharmaceuticals Recent Development
  • 11.4 Bayer
    • 11.4.1 Bayer Company Details
    • 11.4.2 Bayer Business Overview
    • 11.4.3 Bayer Small Molecule Targted Drug Introduction
    • 11.4.4 Bayer Revenue in Small Molecule Targted Drug Business (2015-2020)
    • 11.4.5 Bayer Recent Development
  • 11.5 Exelixis
    • 11.5.1 Exelixis Company Details
    • 11.5.2 Exelixis Business Overview
    • 11.5.3 Exelixis Small Molecule Targted Drug Introduction
    • 11.5.4 Exelixis Revenue in Small Molecule Targted Drug Business (2015-2020)
    • 11.5.5 Exelixis Recent Development
  • 11.6 Abbvie
    • 11.6.1 Abbvie Company Details
    • 11.6.2 Abbvie Business Overview
    • 11.6.3 Abbvie Small Molecule Targted Drug Introduction
    • 11.6.4 Abbvie Revenue in Small Molecule Targted Drug Business (2015-2020)
    • 11.6.5 Abbvie Recent Development
  • 11.7 Boehringer-Ingelheim
    • 11.7.1 Boehringer-Ingelheim Company Details
    • 11.7.2 Boehringer-Ingelheim Business Overview
    • 11.7.3 Boehringer-Ingelheim Small Molecule Targted Drug Introduction
    • 11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Targted Drug Business (2015-2020)
    • 11.7.5 Boehringer-Ingelheim Recent Development
  • 11.8 Eisai
    • 11.8.1 Eisai Company Details
    • 11.8.2 Eisai Business Overview
    • 11.8.3 Eisai Small Molecule Targted Drug Introduction
    • 11.8.4 Eisai Revenue in Small Molecule Targted Drug Business (2015-2020)
    • 11.8.5 Eisai Recent Development
  • 11.9 Pfizer
    • 11.9.1 Pfizer Company Details
    • 11.9.2 Pfizer Business Overview
    • 11.9.3 Pfizer Small Molecule Targted Drug Introduction
    • 11.9.4 Pfizer Revenue in Small Molecule Targted Drug Business (2015-2020)
    • 11.9.5 Pfizer Recent Development
  • 11.10 Bristol-Myers Squibb
    • 11.10.1 Bristol-Myers Squibb Company Details
    • 11.10.2 Bristol-Myers Squibb Business Overview
    • 11.10.3 Bristol-Myers Squibb Small Molecule Targted Drug Introduction
    • 11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Targted Drug Business (2015-2020)
    • 11.10.5 Bristol-Myers Squibb Recent Development
  • 11.11 Roche
    • 10.11.1 Roche Company Details
    • 10.11.2 Roche Business Overview
    • 10.11.3 Roche Small Molecule Targted Drug Introduction
    • 10.11.4 Roche Revenue in Small Molecule Targted Drug Business (2015-2020)
    • 10.11.5 Roche Recent Development
  • 11.12 Bettapharma
    • 10.12.1 Bettapharma Company Details
    • 10.12.2 Bettapharma Business Overview
    • 10.12.3 Bettapharma Small Molecule Targted Drug Introduction
    • 10.12.4 Bettapharma Revenue in Small Molecule Targted Drug Business (2015-2020)
    • 10.12.5 Bettapharma Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Small Molecule Targted Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Targted Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    TKI
    Multitarget Inhibitor
    Others

    Market segment by Application, split into
    Liver Cancer
    Colorectal Cancer
    Lung Cancer
    Gastric Cancer
    Breast Cancer
    Esophageal Cancer
    Others

    Based on regional and country-level analysis, the Small Molecule Targted Drug market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Small Molecule Targted Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Astrazeneca
    Novartis
    Millennium Pharmaceuticals
    Bayer
    Exelixis
    Abbvie
    Boehringer-Ingelheim
    Eisai
    Pfizer
    Bristol-Myers Squibb
    Roche
    Buy now